Skip to main content

Home
Browse by Topic
Issues
Special Series
- Conference Correspondent
  - ASH 2023 - CLL
- Ovarian Cancer Overview
Multimedia
Subscribe

Home
Browse by Topic
Issues
Special Series
- Conference Correspondent
  - ASH 2023 - CLL
- Ovarian Cancer Overview
Multimedia
Subscribe

Brian Dinh, PharmD

Resident Reporter
The University of Oklahoma College of Pharmacy
Oklahoma City, OK

Authored Items

Highlights from Key Meetings in Hematology and Oncology

By Brian Dinh, PharmD; Lisa A. Raedler, PhD, RPh, Medical Writer

TOP-Resident Reporter-September 2013

Efficacy outcomes in acute myeloid leukemia (AML) are poorer with advanced age and the presence of FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD). Read More ›

Highlights from Key Meetings in Hematology and Oncology

By Brian Dinh, PharmD; Lisa A. Raedler, PhD, RPh, Medical Writer

Resident Reporter-September 2013

Efficacy outcomes in acute myeloid leukemia (AML) are poorer with advanced age and the presence of FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD). Read More ›

Back To Top

Home
About
Contact Us
Advertise
Subscribe

© Amplity Health. All Rights Reserved. Privacy Policy.

Get TOP in Your Inbox!

Stay up to date with the latest oncology pharmacy news and insights by subscribing to our eNewsletter.

I have reviewed and consent to the terms of TOP Privacy Policy, and TOP has my permission to retain my information in its database, and to forward pertinent communications to me.